Form 4: Marsh & McLennan CEO John Doyle Executes Stock Options and Sells Shares
SEC Form 4 Filing
CEO John Doyle exercised stock options and sold shares of Marsh & McLennan Companies (MMC) on February 28, 2025, and March 3, 2025, according to a Form 4 filing with the SEC.
Summary
- John Doyle, the President and CEO of Marsh & McLennan Companies, executed transactions involving Marsh & McLennan common stock.
- On February 28, 2025, Doyle vested and received 26,426 shares underlying restricted stock units, with 13,491 shares withheld to cover taxes, related to performance stock units granted on February 23, 2022, for the performance period 2022-2024.
- Also on February 28, 2025, 13,491 shares were disposed of at a price of $233.74.
- On March 3, 2025, Doyle exercised options to acquire 21,080 shares at a price of $63.09 per share.
- On March 3, 2025, Doyle sold 21,080 shares at a price of $237.05 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
Executive stock transactions are common in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Marsh & McLennan's executive compensation practices, including stock options and restricted stock units, are generally in line with those of its peers in the insurance and financial services industries, such as Aon, Willis Towers Watson, and Arthur J. Gallagher & Co.
- The use of Rule 10b5-1 trading plans is a standard practice among corporate executives to avoid accusations of insider trading.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2022-02-23 | Date of grant for performance stock units related to the performance period 2022-2024. |
| 2016-05-01 | Date the stock options were granted. |
| 2017-05-01 | First vesting date of the stock options. |
| 2018-05-01 | Second vesting date of the stock options. |
| 2019-05-01 | Third vesting date of the stock options. |
| 2020-05-01 | Fourth vesting date of the stock options. |
| 2025-02-28 | Vesting and distribution of 26,426 shares underlying restricted stock units; 13,491 shares withheld for taxes; sale of 13,491 shares at $233.74. |
| 2025-03-03 | Exercise of options for 21,080 shares at $63.09; sale of 21,080 shares at $237.05. |
| 2026-04-30 | Expiration date of the stock options. |
| 2025-03-04 | Date of signature on the SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.